Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: A measure of safety or out of date? A retrospective analysis of 975 patients

Europace

Volumn 14, Issue 2, 2012, Pages 217-223

  Guenther, M ^a   Rauwolf, T ^a   Brggemann, B ^a   Gerlach, M ^a   Wssnig N K ^a   Christoph, M ^a   Braun, M U ^a   Strasser, R H ^a   Wunderlich, C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Defibrillation; Electrophysiology tests; ICD

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIGENIN; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; DEATH; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE;

AGE DISTRIBUTION; AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE ANALYSIS; EQUIPMENT SAFETY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84856259355     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur306     Document Type: Article

References (30)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
2. Moss AJ, Greenberg H, Case RB, ZarebaW, Hall WJ, Brown MWet al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5. (Pubitemid 40023973)
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
5. Acomparison of antiarrhythmic-drug therapywith implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.
6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/ AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-e484.
7. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010;31: 2677-87.
8. Vlay SC. The ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: their relevance to the cardiologist, internist and familyphysician. J Invasive Cardiol 2009;21:234-7.
9. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95. (Pubitemid 47428944)
10. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007;30:675-700. (Pubitemid 46656108)
11. Vlay SC. Defibrillation threshold testing in the 21st century: necessary or not? Pacing Clin Electrophysiol 2009;32:565-6.
12. Kolb C, Tzeis S, Zrenner B. Defibrillation threshold testing: tradition or necessity? Pacing Clin Electrophysiol 2009;32:570-2.
13. Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverterdefibrillator: how much is enough? J Cardiovasc Electrophysiol 2006;17:140-5. (Pubitemid 43344864)
14. Quin EM, Cuoco FA, Forcina MS, Coker JB, Yoe RH, Spencer WH III et al. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2011;22:569-72.
15. Roberts BD, Hood RE, Saba MM, Dickfeld TM, Saliaris AP, Shorofsky SR. Defibrillation threshold testing in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2010;33:1342-6.
16. Michowitz Y, Lellouche N, Contractor T, Bourke T, Wiener I, Buch E et al. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 2011;13:683-8.
17. Birnie D, Tung S, Simpson C, Crystal E, Exner D, yala Paredes FA et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008;5:387-90.
18. Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS et al. Defibrillation testing at the time of ICD insertion: An analysis from the Ontario ICD Registry. J Cardiovasc Electrophysiol 2010;21:1344-8.
19. Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: Results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation with Implantable Cardioverter-Defibrillator Implantations). Circulation 2007;115:2382-9. (Pubitemid 46717960)
20. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-8. (Pubitemid 34297872)
21. Theuns DA, Szili-Torok T, Jordaens LJ. Defibrillation efficacy testing: long-term follow-up and mortality. Europace 2005;7:509-15 (Pubitemid 41488092)
22. Gold MR, Kroll MW, Ellenbogen KA. Defibrillation testing at ICD implantation: are we asking the wrong question? Pacing Clin Electrophysiol 2009;32: 567-9.
23. Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB et al. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol 2009;54:1993-2000.
24. Bänsch D. NORDIC ICD (NORDIC Implantable Cardioverter Defibrillator Study). ClinicalTrials gov Identifier: NCT01282918. January 24 2011. http://clinicaltrials.gov/ct2/show/NCT01282918 (8 August 2011, date last accessed).
25. Healey J. Shockless Implant Evaluation (SIMPLE). ClinicalTrials gov Identifier: NCT00800384. September 30 2010 http://clinicaltrials.gov/show/ NCT00800384(8 August 2011, date last accessed).
26. Viskin S, Rosso R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008;5:391-3.
27. Hsia HH, Marchlinski FE. Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev 2002;6:472-81. (Pubitemid 36104466)
28. Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol 2002;25:1114-27. (Pubitemid 34828067)
29. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 2005;14:71-8. (Pubitemid 43004735)
30. Gilman BL, Brewer JE, Kroll K, Kroll MW. Medium voltage therapy for preventing and treating asystole and PEA in ICDs. Conf Proc IEEE Eng Med Biol Soc 2009;2009: 4623-5.